Results of the first interim analysis of the CARMA study to investigate efficacy and safety profile of catumaxomab in clinical practice.
Volker Kunzmann
Consultant or Advisory Role - Consultant
Honoraria - Honoraria for presentations
Jalid Sehouli
Consultant or Advisory Role - Consultant
Honoraria - Honoraria for presentations
Barbara Schmalfeldt
Consultant or Advisory Role - Consultant
Honoraria - Honoraria for presentations
Pauline Wimberger
Consultant or Advisory Role - Consultant
Honoraria - Honoraia for presentations
Christian M. Kurbacher
Research Funding - Funding
G.-F. Tempelhoff
Research Funding - Funding
Udo J. Vanhoefer
Research Funding - Funding
P. Ebeling
Research Funding - Funding
F. Breuer
Research Funding - Funding
Holger Schulz
Research Funding - Funding
Manfred Welslau
Research Funding - Funding
Dominique Finas
Consultant or Advisory Role - Consultant
Honoraria - Funding
Jaqueline Sagasser
Research Funding - Funding
M. Kiehl
Research Funding - Funding
S. Fruehauf
Research Funding - Funding